30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
Acute side effects after definitive stereotactic body radiation therapy (SBRT) for patients with clinically localized or locally advanced prostate cancer: a single institution prospective study
Jorgo K, Polgar C, Stelczer G, Major T, Gesztesi L, Agoston P | Radiol Oncol | 2021
Bleeding Risk Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer in Men on Baseline Anticoagulant or Antiplatelet Therapy
Pepin A, Shah S, Pernia M, Lei S, Ayoob M, Danner M, Yung T, Collins BT, Suy S, Aghdam N, Collins SP | Front Oncol | 2021
Five-year outcomes of stereotactic body radiation therapy (SBRT) for prostate cancer: the largest experience in China
Zhao X, Ye Y, Yu H, Jiang L, Cheng C, Guo X, Ju X, Zhu X, Zhang H. | J Cancer Res Clin Oncol | 2021
Bothersome Hematospermia Following Stereotactic Body Radiation Therapy for Prostate Cancer
Sarthak Shah, Tamir Sholklapper , Michael Creswell, Abigail Pepin , Jonathan Cantalino, Ryan Andrew Hankins, Simeng Suy, Sean P Collins | Front Oncol | 2021
Short-Term Outcomes and Clinical Efficacy of Stereotactic Body Radiation Therapy (SBRT) for Oligometastases of Prostate Cancer in China
Chenyang Xu, Xianzhi Zhao, Xiaoping Ju, Yuxin Shen, Min Qu, Yusheng Ye, Xiaoyan Wang, Chunshan Yu, Xu Gao, Huojun Zhang | Front Oncol | 2022
High Dose “HDR-Like” Prostate SBRT: PSA 10-Year Results From a Mature, Multi-Institutional Clinical Trial
Fuller DB, Crabtree T, Kane BL, Medbery CA, Pfeffer R, Gray JR, Peddada A, Royce TJ, Chen RC | Front Oncol | 2022
Single fraction radiosurgery for the treatment of renal tumors
Staehler M, Bader M, Schlenker B, Casuscelli J, Karl A, Roosen A, Stief CG, Bex A, Wowra B, Muacevic A | J Urol | 2015
Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma
Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR, Machtay M, Ellis RJ | Radiother Oncol | 2015
Stereotactic Body Radiotherapy for Large Primary Renal Cell Carcinoma
S Kaidar-Person O, Price A, Schreiber E, Zagar TM, Chen RC | Clin Genitourin Cancer | 2017
Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function
Senger C, Conti A, Kluge A, Pasemann D, Kufeld M, Acker G, Lukas M, Grün A, Kalinauskaite G, Budach V, Waiser J, Stromberger C | BMC Urol | 2019
Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes
Michael Staehler, Tina Schuler, Annabel Spek, Severin Rodler, Alexander Tamalunas, Christoph Fürweger, Alexander Muacevic | Cureus | 2022
Robotic stereotactic body radiotherapy for the management of adrenal gland metastases: a bi-institutional analysis
Felix Ehret, David Kaul, Markus Kufeld, Clara Vom Endt, Volker Budach, Carolin Senger , Christoph Fürweger , Alfred Haidenberger , Alexander Muacevic | J Cancer Res Clin Oncol | 2022
Re-irradiation with SBRT for Pancreatic Cancer
Zhang, Huo Jun
Treatment of Pancreas Cancer with the CyberKnife® System
Anand Mahadevan
Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
Dagoglu N, Callery M, Moser J, Tseng J, Kent T, Bullock A, Miksad R, Mancias JD, Mahadevan A | J Cancer | 2016
Role of the TomoTherapy® System in the Treatment of Rectal Cancer
Berardino De Bari
A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma
Huang CM, Huang MY, Tsai HL, Huang CW, Ma CJ, Lin CH, Huang CJ, Wang JY | J Radiat Res | 2017
Concomitant dose escalation with image-guided Tomotherapy in locally advanced mid-low rectal cancer: a single-center study
Zhao J, Liu X, Wang W, Hu K, Zhang F, Hou X, Meng Q | Cancer Manag Res | 2019
Neoadjuvant chemoradiotherapy delivered with helical tomotherapy under daily image guidance for rectal cancer patients: efficacy and safety in a large, multi-institutional series
De Bari B, Franzetti-Pellanda A, Saidi A, Biggiogero M, Hahnloser D, Montemurro M, Bourhis J, Zeverino M, Ozsahin M | J Cancer Res Clin Oncol | 2019
From TBI to TMI for Advanced Onco-Hematological Diseases
Stefano Vagge
Influencing Factors of Total Skin Irradiation With Helical Tomotherapy
Wang H, Pi Y, Guo Y, Pei X, and Xu XG | Front Oncol | 2022
A Helical tomotherapy as a robust low-dose treatment alternative for total skin irradiation
Haraldsson A, Engleson J, Bäck SÅJ, Engelholm S, Engström PE | J Appl Clin Med Phys | 2019